Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joeri W van Straalen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Pediatrics|April 23, 2022
A Diagnostic Prediction Model for Separating Juvenile Idiopathic Arthritis and Chronic Musculoskeletal Pain SyndromeJoeri W van Straalen, Martine van Stigt Thans, Nico M Wulffraat, et al.
Pediatric Rheumatology Online Journal|August 7, 2023
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysisMohamad Hamad Saied, Laura van der Griend, Joeri W van Straalen, et al.
European Journal of Pediatrics|August 14, 2024
E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?Elham Orouk Awaad, Lana Khoury, Joeri W van Straalen, et al.
RMD Open|April 24, 2023
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritisJoeri W van Straalen, Görkem Akay, Carlyn V Kouwenberg, et al.
Vaccine|April 9, 2023
Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up studyMohamad Hamad Saied, Joeri W van Straalen, Sytze de Roock, et al.
Vaccine|July 29, 2023
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritisMohamad Hamad Saied, Joeri W van Straalen, Sytze de Roock, et al.
Pediatric Rheumatology Online Journal|November 19, 2022
Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registryJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
Pediatric Rheumatology Online Journal|February 22, 2023
Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registryJoeri W van Straalen, Laurie Baas, Gabriella Giancane, et al.
Pediatric Rheumatology Online Journal|November 15, 2022
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort studyJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
Pediatric Rheumatology Online Journal|July 20, 2023
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort studyMilou Ohm, Joeri W van Straalen, Gerrie de Joode-Smink, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Pediatrics|April 23, 2022
A Diagnostic Prediction Model for Separating Juvenile Idiopathic Arthritis and Chronic Musculoskeletal Pain SyndromeJoeri W van Straalen, Martine van Stigt Thans, Nico M Wulffraat, et al.
Pediatric Rheumatology Online Journal|August 7, 2023
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysisMohamad Hamad Saied, Laura van der Griend, Joeri W van Straalen, et al.
European Journal of Pediatrics|August 14, 2024
E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?Elham Orouk Awaad, Lana Khoury, Joeri W van Straalen, et al.
RMD Open|April 24, 2023
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritisJoeri W van Straalen, Görkem Akay, Carlyn V Kouwenberg, et al.
Vaccine|April 9, 2023
Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up studyMohamad Hamad Saied, Joeri W van Straalen, Sytze de Roock, et al.
Vaccine|July 29, 2023
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritisMohamad Hamad Saied, Joeri W van Straalen, Sytze de Roock, et al.
Pediatric Rheumatology Online Journal|November 19, 2022
Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registryJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
Pediatric Rheumatology Online Journal|February 22, 2023
Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registryJoeri W van Straalen, Laurie Baas, Gabriella Giancane, et al.
Pediatric Rheumatology Online Journal|November 15, 2022
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort studyJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
Pediatric Rheumatology Online Journal|July 20, 2023
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort studyMilou Ohm, Joeri W van Straalen, Gerrie de Joode-Smink, et al.
Pageof 2